MiNK Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel, first-in-class invariant natural killer T (iNKT) cell therapies to transform the lives of patients with cancer.
Data provided by Kaleidoscope.
Events and Presentations
December 1, 2022 at 4:45 PM EST
November 10, 2022 at 4:00 PM EST
November 3, 2022 at 8:30 AM EDT